Acute coronary syndromes

AHA 2021 | RAPID CABG: Safety of Early Surgical Intervention in Acute Coronary Syndrome

Suspending ticagrelor a couple of days before surgery was non-inferior to waiting 5-6 days in terms of...

solaci - 23 November, 2021

Acute coronary syndromes

TCT 2021 | iFR-SWEDEHEART: 5 Years to Trust FFR Is Equivalent to iFR

The 5-year followup of the iFR-SWEDEHEART has confirmed the safety and efficacy of using either FFR or...

solaci - 9 November, 2021

Acute coronary syndromes

First Guidelines Focused Specifically on Chest Pain Management

Many years of developing and waiting have led us to the latest guidelines published by ACC/AHA together...

solaci - 2 November, 2021

Acute coronary syndromes

STOPDAPT-2 ACS: One-Month DAPT NOT Enough in acute patients

One-month dual antiplatelet therapy (DAPT) in patients undergoing acute coronary syndrome (ACS) did not reach the safety...

solaci - 7 October, 2021

Acute coronary syndromes

Non-Culprit Vessel Angioplasty in the Elderly: Choosing the Right Cases Is Important

This large analysis found no benefit at a 1-year follow-up to angioplasty of non-culprit vessels in elderly...

solaci - 9 September, 2021

Acute coronary syndromes

FLOWER-MI Sub-Studies Coming Out Generate More Questions about FFR

The FLOWER-MI (presented simultaneously at ACC 2021 and NEJM) hit FFR hard. Its outcomes showed that STEMI...

solaci - 8 September, 2021

Acute coronary syndromes

ESC 2021 | COVERT-MI: Colchicine Attempts to Reduce Infarct Size

Colchicine does not offer protection against myocardial injury in ST-segment elevation myocardial infarction when administered during reperfusion...

solaci - 1 September, 2021

Acute coronary syndromes

ESC 2021 | ISAR-REACT 5: Prasugrel Superior to Ticagrelor in ACS across Kidney Function Spectrum

When we have to choose between two potent P2Y12 receptor inhibitors for a patient undergoing ACS with...

solaci - 31 August, 2021

Acute coronary syndromes

AHA 2021 | RAPID CABG: Safety of Early Surgical Intervention in Acute Coronary Syndrome

TCT 2021 | iFR-SWEDEHEART: 5 Years to Trust FFR Is Equivalent to iFR

First Guidelines Focused Specifically on Chest Pain Management

STOPDAPT-2 ACS: One-Month DAPT NOT Enough in acute patients

Non-Culprit Vessel Angioplasty in the Elderly: Choosing the Right Cases Is Important

FLOWER-MI Sub-Studies Coming Out Generate More Questions about FFR

ESC 2021 | COVERT-MI: Colchicine Attempts to Reduce Infarct Size

ESC 2021 | ISAR-REACT 5: Prasugrel Superior to Ticagrelor in ACS across Kidney Function Spectrum

Últimas Noticias

ACC-2025 Congress Second Day Key Studies

ACC 2025 | FAME 3: FFR Guided PCI vs CABG 5 Year Outcomes.

ACC 2025 | API-CAT: Reduced vs. Full Dose Extended Anticoagulation in Patients with Cancer Related VTE

Noticias Institucionales

Watch our event on Evidence and Controversies of Renal Denervation in 2025

March 26 – SOLACI Webinar: Evidence and Controversies in Renal Denervation in 2025

Uruguay Sessions 2025 | Young Interventional Cardiologists Contest

Accesos